143 related articles for article (PubMed ID: 9589057)
1. [Genetic testing for ret mutation for early diagnosis and treatment in familial medullary thyroid carcinoma: a case report].
Nagaoka H; Iino Y; Takei H; Maemura M; Horiguchi J; Horii Y; Matumoto H; Koibuchi Y; Ninomiya J; Yokoe T; Oyama T; Morishita Y
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():481-5. PubMed ID: 9589057
[TBL] [Abstract][Full Text] [Related]
2. Surgical strategy in a kindred with a rare RET protooncogene mutation of variable penetrance with regard to multiple endocrine neoplasia.
Colombo-Benkmann M; Brämswig J; Höppner W; Gellner R; Hengst K; Böcker W; Senninger N
World J Surg; 2002 Oct; 26(10):1286-90. PubMed ID: 12205548
[TBL] [Abstract][Full Text] [Related]
3. Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG-->ATG) mutation.
Feldman GL; Edmonds MW; Ainsworth PJ; Schuffenecker I; Lenoir GM; Saxe AW; Talpos GB; Roberson J; Petrucelli N; Jackson CE
Surgery; 2000 Jul; 128(1):93-8. PubMed ID: 10876191
[TBL] [Abstract][Full Text] [Related]
4. Is thyroidectomy necessary in RET mutations carriers of the familial medullary thyroid carcinoma syndrome?
Hansen HS; Torring H; Godballe C; Jäger AC; Nielsen FC
Cancer; 2000 Aug; 89(4):863-7. PubMed ID: 10951350
[TBL] [Abstract][Full Text] [Related]
5. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
[TBL] [Abstract][Full Text] [Related]
6. Presentation of a kindred with familial medullary thyroid carcinoma and Cys611Phe mutation of the RET proto-oncogene demonstrating low grade malignancy.
Siggelkow H; Melzer A; Nolte W; Karsten K; Hoppner W; Hufner M
Eur J Endocrinol; 2001 May; 144(5):467-73. PubMed ID: 11331212
[TBL] [Abstract][Full Text] [Related]
7. Unilateral surgery supported by germline RET oncogene mutation analysis in patients with sporadic medullary thyroid carcinoma.
Miyauchi A; Matsuzuka F; Hirai K; Yokozawa T; Kobayashi K; Kuma S; Kuma K; Futami H; Yamaguchi K
World J Surg; 2000 Nov; 24(11):1367-72. PubMed ID: 11038208
[TBL] [Abstract][Full Text] [Related]
8. [Usefulness of RET proto-oncogene in the diagnosis of hereditary-type medullary carcinoma of the thyroid. Correlation with surgical findings].
Carreño M; Girbés J; Malluguiza R; Serrano S; Matias-Guiu X; Tudela J; Alfayate R; Lagarda H
Acta Otorrinolaringol Esp; 2001; 52(1):57-63. PubMed ID: 11269881
[TBL] [Abstract][Full Text] [Related]
9. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
Sansó G; Domené HM; Iorcansky S; Barontini M
Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
[TBL] [Abstract][Full Text] [Related]
10. [Clinical diagnosis and treatment of familial medullary thyroid carcinoma caused by a p.C618Y RET proto-oncogene mutation in a Chinese pedigree].
Zhao JQ; Guo L; Qi XP; Chen ZG; Wang KJ; Lou JL; Yu XH; Cheng J; Jin HY; Li XL; Ying RB; Zhang XN
Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(6):440-4. PubMed ID: 23660264
[TBL] [Abstract][Full Text] [Related]
11. Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients.
Niccoli-Sire P; Murat A; Rohmer V; Franc S; Chabrier G; Baldet L; Maes B; Savagner F; Giraud S; Bezieau S; Kottler ML; Morange S; Conte-Devolx B;
J Clin Endocrinol Metab; 2001 Aug; 86(8):3746-53. PubMed ID: 11502806
[TBL] [Abstract][Full Text] [Related]
12. Familial medullary thyroid carcinoma (FMTC). Study of one family (treatment criteria).
Carli AF; Mariani F; Di Cosmo L; Giuli R; Neri A
Eur J Surg Oncol; 2001 Mar; 27(2):162-4. PubMed ID: 11289752
[TBL] [Abstract][Full Text] [Related]
13. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.
Romei C; Elisei R; Pinchera A; Ceccherini I; Molinaro E; Mancusi F; Martino E; Romeo G; Pacini F
J Clin Endocrinol Metab; 1996 Apr; 81(4):1619-22. PubMed ID: 8636377
[TBL] [Abstract][Full Text] [Related]
14. Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.
Vieira AE; Mello MP; Elias LL; Lau IF; Maciel LM; Moreira AC; Castro M
Horm Metab Res; 2002 Apr; 34(4):202-6. PubMed ID: 11987030
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations.
Kambouris M; Jackson CE; Feldman GL
Hum Mutat; 1996; 8(1):64-70. PubMed ID: 8807338
[TBL] [Abstract][Full Text] [Related]
16. Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations.
Miyauchi A; Matsuzuka F; Hirai K; Yokozawa T; Kobayashi K; Ito Y; Nakano K; Kuma K; Futami H; Yamaguchi K
World J Surg; 2002 Aug; 26(8):1023-8. PubMed ID: 12016484
[TBL] [Abstract][Full Text] [Related]
17. [Study of RET protooncogene in multiple endocrine neoplasm 2A and in familial medullary thyroid carcinoma. Clinical pathological findings in asymptomatic carriers].
Belli S; Storani ME; Dourisboure RJ; Podestá EJ; Solano AR
Medicina (B Aires); 2003; 63(1):41-5. PubMed ID: 12673960
[TBL] [Abstract][Full Text] [Related]
18. A novel germ-line point mutation in RET exon 8 (Gly(533)Cys) in a large kindred with familial medullary thyroid carcinoma.
Da Silva AM; Maciel RM; Da Silva MR; Toledo SR; De Carvalho MB; Cerutti JM
J Clin Endocrinol Metab; 2003 Nov; 88(11):5438-43. PubMed ID: 14602786
[TBL] [Abstract][Full Text] [Related]
19. Medullary thyroid carcinoma: recent advances and management update.
Marsh DJ; Learoyd DL; Robinson BG
Thyroid; 1995 Oct; 5(5):407-24. PubMed ID: 8563482
[TBL] [Abstract][Full Text] [Related]
20. New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour.
Frank-Raue K; Döhring J; Scheumann G; Rondot S; Lorenz A; Schulze E; Dralle H; Raue F; Leidig-Bruckner G
Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):550-3. PubMed ID: 20013610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
